DOAC
STUDY00003241
Approved small_molecule completed
Quick answer
DOAC for Ventricular Tachycardia is a Approved program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Ventricular Tachycardia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed